NCT02965573 2024-08-28A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle WeaknessargenxPhase 2 Completed24 enrolled 28 charts
NCT06221501 2024-01-24Perioperative Efgartigimod for Thymoma and Myasthenia GravisShanghai Zhongshan HospitalPhase 2 Not yet recruiting30 enrolled